173 related articles for article (PubMed ID: 30896450)
1. RhoBTB1 protects against hypertension and arterial stiffness by restraining phosphodiesterase 5 activity.
Mukohda M; Fang S; Wu J; Agbor LN; Nair AR; Ibeawuchi SC; Hu C; Liu X; Lu KT; Guo DF; Davis DR; Keen HL; Quelle FW; Sigmund CD
J Clin Invest; 2019 Mar; 129(6):2318-2332. PubMed ID: 30896450
[TBL] [Abstract][Full Text] [Related]
2. Cullin-3 regulates vascular smooth muscle function and arterial blood pressure via PPARγ and RhoA/Rho-kinase.
Pelham CJ; Ketsawatsomkron P; Groh S; Grobe JL; de Lange WJ; Ibeawuchi SR; Keen HL; Weatherford ET; Faraci FM; Sigmund CD
Cell Metab; 2012 Oct; 16(4):462-72. PubMed ID: 23040068
[TBL] [Abstract][Full Text] [Related]
3. RhoBTB1 reverses established arterial stiffness in angiotensin II-induced hypertension by promoting actin depolymerization.
Fang S; Wu J; Reho JJ; Lu KT; Brozoski DT; Kumar G; Werthman AM; Silva SD; Muskus Veitia PC; Wackman KK; Mathison AJ; Teng BQ; Lin CW; Quelle FW; Sigmund CD
JCI Insight; 2022 May; 7(9):. PubMed ID: 35358093
[TBL] [Abstract][Full Text] [Related]
4. The 2023 Walter B. Cannon Award Lecture: Mechanisms Regulating Vascular Function and Blood Pressure by the PPARγ-RhoBTB1-CUL3 Pathway.
Sigmund CD
Function (Oxf); 2024; 5(1):zqad071. PubMed ID: 38196837
[TBL] [Abstract][Full Text] [Related]
5. Conditional deletion of smooth muscle Cullin-3 causes severe progressive hypertension.
Agbor LN; Nair AR; Wu J; Lu KT; Davis DR; Keen HL; Quelle FW; McCormick JA; Singer JD; Sigmund CD
JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31184598
[TBL] [Abstract][Full Text] [Related]
6. Cullin-3 mutation causes arterial stiffness and hypertension through a vascular smooth muscle mechanism.
Agbor LN; Ibeawuchi SC; Hu C; Wu J; Davis DR; Keen HL; Quelle FW; Sigmund CD
JCI Insight; 2016 Nov; 1(19):e91015. PubMed ID: 27882355
[TBL] [Abstract][Full Text] [Related]
7. PPARγ and RhoBTB1 in hypertension.
Fang S; Sigmund CD
Curr Opin Nephrol Hypertens; 2020 Mar; 29(2):161-170. PubMed ID: 31789920
[TBL] [Abstract][Full Text] [Related]
8. RhoBTB1 interacts with ROCKs and inhibits invasion.
Haga RB; Garg R; Collu F; Borda D'Agua B; Menéndez ST; Colomba A; Fraternali F; Ridley AJ
Biochem J; 2019 Sep; 476(17):2499-2514. PubMed ID: 31431478
[TBL] [Abstract][Full Text] [Related]
9. Dysfunction of Cullin 3 RING E3 ubiquitin ligase causes vasoconstriction and increased sodium reabsorption in diabetes.
Zhang Y; Guo Q; Jiang G; Zhang C
Arch Biochem Biophys; 2021 Oct; 710():109000. PubMed ID: 34343486
[TBL] [Abstract][Full Text] [Related]
10. Phosphodiesterase 5 inhibition ameliorates angiotensin II-dependent hypertension and renal vascular dysfunction.
Thieme M; Sivritas SH; Mergia E; Potthoff SA; Yang G; Hering L; Grave K; Hoch H; Rump LC; Stegbauer J
Am J Physiol Renal Physiol; 2017 Mar; 312(3):F474-F481. PubMed ID: 28052870
[TBL] [Abstract][Full Text] [Related]
11. Structure and Function of RhoBTB1 Required for Substrate Specificity and Cullin-3 Ubiquitination.
Kumar G; Fang S; Golosova D; Lu KT; Brozoski DT; Vazirabad I; Sigmund CD
Function (Oxf); 2023; 4(5):zqad034. PubMed ID: 37575477
[TBL] [Abstract][Full Text] [Related]
12. The Rho/Rac exchange factor Vav2 controls nitric oxide-dependent responses in mouse vascular smooth muscle cells.
Sauzeau V; Sevilla MA; Montero MJ; Bustelo XR
J Clin Invest; 2010 Jan; 120(1):315-30. PubMed ID: 20038798
[TBL] [Abstract][Full Text] [Related]
13. Rho kinase and hypertension.
Wirth A
Biochim Biophys Acta; 2010 Dec; 1802(12):1276-84. PubMed ID: 20460153
[TBL] [Abstract][Full Text] [Related]
14. Essential Role of Smooth Muscle STIM1 in Hypertension and Cardiovascular Dysfunction.
Kassan M; Ait-Aissa K; Radwan E; Mali V; Haddox S; Gabani M; Zhang W; Belmadani S; Irani K; Trebak M; Matrougui K
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1900-9. PubMed ID: 27470514
[TBL] [Abstract][Full Text] [Related]
15. Ste20-related kinase SLK phosphorylates Ser188 of RhoA to induce vasodilation in response to angiotensin II Type 2 receptor activation.
Guilluy C; Rolli-Derkinderen M; Loufrani L; Bourgé A; Henrion D; Sabourin L; Loirand G; Pacaud P
Circ Res; 2008 May; 102(10):1265-74. PubMed ID: 18420945
[TBL] [Abstract][Full Text] [Related]
16. Failure to vasodilate in response to salt loading blunts renal blood flow and causes salt-sensitive hypertension.
Wu J; Agbor LN; Fang S; Mukohda M; Nair AR; Nakagawa P; Sharma A; Morgan DA; Grobe JL; Rahmouni K; Weiss RM; McCormick JA; Sigmund CD
Cardiovasc Res; 2021 Jan; 117(1):308-319. PubMed ID: 32428209
[TBL] [Abstract][Full Text] [Related]
17. Resistance to the nitric oxide/cyclic guanosine 5'-monophosphate/protein kinase G pathway in vascular smooth muscle cells from the obese Zucker rat, a classical animal model of insulin resistance: role of oxidative stress.
Russo I; Del Mese P; Doronzo G; Mattiello L; Viretto M; Bosia A; Anfossi G; Trovati M
Endocrinology; 2008 Apr; 149(4):1480-9. PubMed ID: 18079207
[TBL] [Abstract][Full Text] [Related]
18. New Nitric Oxide Donor NCX 1443: Therapeutic Effects on Pulmonary Hypertension in the SAD Mouse Model of Sickle Cell Disease.
Abid S; Kebe K; Houssaïni A; Tomberli F; Marcos E; Bizard E; Breau M; Parpaleix A; Tissot CM; Maitre B; Lipskaia L; Derumeaux G; Bastia E; Mekontso-Dessap A; Adnot S
J Cardiovasc Pharmacol; 2018 May; 71(5):283-292. PubMed ID: 29438213
[TBL] [Abstract][Full Text] [Related]
19. Effect of angiotensin II-induced arterial hypertension on the voltage-dependent contractions of mouse arteries.
Fransen P; Van Hove CE; Leloup AJ; Schrijvers DM; De Meyer GR; De Keulenaer GW
Pflugers Arch; 2016 Feb; 468(2):257-67. PubMed ID: 26432297
[TBL] [Abstract][Full Text] [Related]
20. Lower urinary tract symptoms/benign prostatic hypertrophy and vascular function: Role of the nitric oxide-phosphodiesterase type 5-cyclic guanosine 3',5'-monophosphate pathway.
Higashi Y
Int J Urol; 2017 Jun; 24(6):412-424. PubMed ID: 28332240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
